Name | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
---|---|
Synonyms |
N-Demethyl-6-O-methylerythromycin
3&3'-N-demethyl-6-O-methylerythromycin A de(N-methyl) erythromycin A N-Demethylclarithromycin de(N-methyl)-6-O-methyl erythromycin 4'-desmethylclarithromycin N-des-methylclarithromycin Claricid Impurity 1 |
Density | 1.18±0.1 g/cm3 (20 ºC 760 Torr) |
---|---|
Melting Point | 231-233 ºC |
Molecular Formula | C37H67NO13 |
Molecular Weight | 733.92700 |
Exact Mass | 733.46100 |
PSA | 191.70000 |
LogP | 2.48840 |
RIDADR | NONH for all modes of transport |
---|
~92% 101666-68-6 |
Literature: RIB-X-PHARMACEUTICALS, INC. Patent: WO2008/106204 A1, 2008 ; Location in patent: Page/Page column 112 ; |
~% 101666-68-6 |
Literature: US2009/76253 A1, ; Page/Page column 40 ; |
Precursor 1 | |
---|---|
DownStream 0 |